314 Bibliografia 1. Pizzo PA. Management of Patients With Fever and Neutropenia Through the Arc of Time: A Narrative Review. Ann Intern Med. 2019 Mar 19;170(6):389-397 2. Averbuch D, Orasch C, Cordonnier C, et al; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013 Dec;98(12):1826-35 3. Mikulska M, Averbuch D, Tissot F, et al. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Infect. 2018 Jan;76(1):20-37 4. Girmenia C, Viscoli C, Piciocchi A, Cudillo L, Botti S, Errico A, Sarmati L, Ciceri F, Locatelli F, Giannella M, Bassetti M, Tascini C, Lombardini L, Majolino I, Farina C, Luzzaro F, Rossolini GM, Rambaldi A. Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement. Haematologica. 2015 Sep;100(9):e373-6 5. Sculier JP, Weerts D, Klastersky J. Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy. Eur J Cancer Clin Oncol. 1984 Jan;20(1):55-60 6. Klastersky J, Zinner SH, Calandra T, et al. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol. 1988;24 Suppl 1:S35-45 7. Trecarichi EM, Tumbarello M, Caira M, et al. Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies. Haematologica. 2011 Jan;96(1):e1-3 8. Trecarichi EM, Pagano L, Candoni A, et al; HeMABIS Registry— SEIFEM Group, Italy. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect. 2015 Apr;21(4):337-43 9. Trecarichi EM, Pagano L, Martino B, et al; Haematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS) registry - Sorveglianza Epidemiologica Infezioni Funginein Emopatie Maligne(SEIFEM) group, Italy. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. Am J Hematol. 2016 Nov;91(11):1076-1081 10. Cattaneo C, Zappasodi P, Mancini V, et al. Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel). Ann Hematol. 2016 Dec;95(12):1955-1963 11. Girmenia C, Bertaina A, Piciocchi A, et al; Gruppo Italiano Trapianto di Midollo Osseo (GITMO) and Associazione Microbiologi Clinici Italiani (AMCLI). Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. Clin Infect Dis. 2017 Nov 13;65(11):1884-1896 12. Trecarichi EM, Giuliano G, Cattaneo C, et al; Haematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS) registry–Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne (SEIFEM) group, Italy. Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey. PLoS One. 2019 Oct 29;14(10):e0224465 13. Landi F, Bandettini R, Rotulo GA, et al. Resistance to Antibiotics of Uropathogen Bacteria Isolated From Urine and Blood in Pediatric Cancer Patients: A Single Center, 12-year Study. Pediatr Infect Dis J. 2020 Dec;39(12):1106-1110 14. Girmenia C, Serrao A, Canichella M. Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries. Mediterr J Hematol Infect Dis. 2016 Jul 1;8(1):e2016032 15.https://www.ecdc.europa.eu/sites/default/files/documents/ Joint-WHO-ECDC-AMR-report-2022.pdf 16. Cattaneo C, Di Blasi R, Skert C, et al; SEIFEM Group. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. Ann Hematol. 2018 Sep;97(9):17171726 17. Averbuch D, Tridello G, Hoek J, Mikulska M, Pabst T, Yaňez San Segundo L, Akan H, Özçelik T, Donnini I, Klyasova G, Botelho de Sousa A, Zuckerman T, Tecchio C, de la Camara R, Aki SZ, Ljungman P, Gülbas Z, Nicolas-Virelizier E, Calore E, Perruccio K, Ram R, Annaloro C, Martino R, Avni B, Shaw PJ, Jungova A, Codeluppi K, O'Brien T, Waszczuk-Gajda A, Batlle M, Pouli A, Lueck C, Gil L, Iacobelli S, Styczynski J, Engelhard D, Cesaro S. Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality. J Infect. 2020 Dec;81(6):882-894 18. Mikulska M, Averbuch D, Tissot F, et al. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Infect. 2018 Jan;76(1):20-37 19. Egan G, Robinson PD, Martinez JPD, et al. Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials. Cancer Med. 2019 Aug;8(10):4536-4546 20. Gafter-Gvili A, Fraser A, Paul M, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev. 2012;1:CD004386 21. https://www.cdc.gov/infectioncontrol/pdf/guidelines/mdro-guidelines.pdf 22. Micozzi A, Assanto GM, Cesini L, Minotti C, Cartoni C, Capria S, Ciotti G, Alunni Fegatelli D, Donzelli L, Martelli M, Gentile G. Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic. JAC Antimicrob Resist. 2021 Nov 17;3(4):dlab167. 23. Laganà A, Ferri G, Passucci M, Salvatori M, Bisegna ML, Paoletti F, Aji F, Breccia M, Brunetti GA, Morano GS, Annechini G, Carmosino I, Martelli M, Girmenia C. Reduced Klebsiella pneumoniae carbapenemase producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during Sars-CoV-2 pandemic period. Infect Control Hosp Epidemiol. 2022 Apr 11:1-6. doi: 10.1017/ice.2022.92 24. Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013 Dec;98(12):1826-35. 25. Martinez-Nadal G, Puerta-Alcalde P, Gudiol C, Cardozo C, Albasanz-Puig A, Marco F, Laporte-Amargós J, Moreno-García E, Domingo-Doménech E, Chumbita M, Martínez JA, Soriano A, Carratalà J, Garcia-Vidal C. Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance. Clin Infect Dis. 2020 Mar 3;70(6):1068-1074 26. Micozzi A, Gentile G, Santilli S, Minotti C, Capria S, Moleti ML, Barberi W, Cartoni C, Trisolini SM, Testi AM, Iori AP, Bucaneve G, Foà R. Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae. BMC Infect Dis. 2021 Oct 19;21(1):1079.
RkJQdWJsaXNoZXIy ODUzNzk5